Cervical cancer advances give hope to poor (Reuters)
Font size:
Reuters - New screening tests and effective
vaccines from Merck & Co and GlaxoSmithKline make tackling
cervical cancer in poor countries a real possibility for the
first time, researchers said on Thursday.
Add to:
del.icio.us |
Digg
del.icio.us |
Digg
Email to a friend
Print version
Plain textRate this article
Comments (0 posted):
Post your comment